We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
Read MoreHide Full Article
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $320.37, demonstrating a +1.58% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.21%. Meanwhile, the Dow gained 0.25%, and the Nasdaq, a tech-heavy index, added 0.45%.
Heading into today, shares of the largest U.S. health insurer had gained 25.71% over the past month, outpacing the Medical sector's gain of 5.47% and the S&P 500's gain of 3.07%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. It is anticipated that the company will report an EPS of $2.87, marking a 59.86% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $113.54 billion, up 12.61% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $16.21 per share and revenue of $448.87 billion. These totals would mark changes of -41.4% and +12.14%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.08% higher. UnitedHealth Group currently has a Zacks Rank of #5 (Strong Sell).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 19.46. For comparison, its industry has an average Forward P/E of 17.67, which means UnitedHealth Group is trading at a premium to the group.
It is also worth noting that UNH currently has a PEG ratio of 2.04. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - HMOs industry had an average PEG ratio of 1.18.
The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 230, finds itself in the bottom 7% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why UnitedHealth Group (UNH) Outpaced the Stock Market Today
UnitedHealth Group (UNH - Free Report) ended the recent trading session at $320.37, demonstrating a +1.58% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily gain of 0.21%. Meanwhile, the Dow gained 0.25%, and the Nasdaq, a tech-heavy index, added 0.45%.
Heading into today, shares of the largest U.S. health insurer had gained 25.71% over the past month, outpacing the Medical sector's gain of 5.47% and the S&P 500's gain of 3.07%.
The upcoming earnings release of UnitedHealth Group will be of great interest to investors. It is anticipated that the company will report an EPS of $2.87, marking a 59.86% fall compared to the same quarter of the previous year. Meanwhile, our latest consensus estimate is calling for revenue of $113.54 billion, up 12.61% from the prior-year quarter.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $16.21 per share and revenue of $448.87 billion. These totals would mark changes of -41.4% and +12.14%, respectively, from last year.
It's also important for investors to be aware of any recent modifications to analyst estimates for UnitedHealth Group. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.08% higher. UnitedHealth Group currently has a Zacks Rank of #5 (Strong Sell).
Looking at valuation, UnitedHealth Group is presently trading at a Forward P/E ratio of 19.46. For comparison, its industry has an average Forward P/E of 17.67, which means UnitedHealth Group is trading at a premium to the group.
It is also worth noting that UNH currently has a PEG ratio of 2.04. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - HMOs industry had an average PEG ratio of 1.18.
The Medical - HMOs industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 230, finds itself in the bottom 7% echelons of all 250+ industries.
The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.